DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 141 filers reported holding DIPLOMAT PHARMACY INC in Q4 2019. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $377,000 | – | 94,260 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandhill Capital Partners LLC | 369,015 | $12,916,000 | 4.04% |
| OBERWEIS ASSET MANAGEMENT INC/ | 237,515 | $8,313,000 | 2.47% |
| WEATHERBIE CAPITAL, LLC | 259,175 | $9,071,000 | 1.29% |
| Summit Creek Advisors LLC | 216,385 | $7,573,000 | 1.29% |
| Cambridge Investment Research Advisors, Inc. | 1,700,106 | $59,504,000 | 1.26% |
| Hood River Capital Management LLC | 265,388 | $9,289,000 | 1.24% |
| Sivik Global Healthcare LLC | 65,000 | $2,275,000 | 1.13% |
| Friedberg Investment Management | 63,430 | $2,220,000 | 1.05% |
| Granite Investment Partners, LLC | 342,839 | $12,000,000 | 0.95% |
| Tributary Capital Management, LLC | 176,289 | $6,170,000 | 0.90% |